![Is benign MS really benign? What a meaningful classification beyond the EDSS must take into consideration - ScienceDirect Is benign MS really benign? What a meaningful classification beyond the EDSS must take into consideration - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211034820305605-gr4.jpg)
Is benign MS really benign? What a meaningful classification beyond the EDSS must take into consideration - ScienceDirect
![Jochen ULZHEIMER | Ltd. Oberarzt | Caritas Krankenhaus Bad Mergentheim, Bad Mergentheim | Neurologie Jochen ULZHEIMER | Ltd. Oberarzt | Caritas Krankenhaus Bad Mergentheim, Bad Mergentheim | Neurologie](https://www.researchgate.net/profile/Jochen-Ulzheimer/publication/271534670/figure/fig4/AS:272093984063562@1441883669805/Morphology-of-B-cell-spots-measured-directly-ex-vivo-and-after-polyclonal-stimulation_Q320.jpg)
Jochen ULZHEIMER | Ltd. Oberarzt | Caritas Krankenhaus Bad Mergentheim, Bad Mergentheim | Neurologie
![Effect of applying inclusion and exclusion criteria of phase III clinical trials to multiple sclerosis patients in routine clinical care - Kris Oliver Jalusic, David Ellenberger, Paulus Rommer, Alexander Stahmann, Uwe Zettl, Effect of applying inclusion and exclusion criteria of phase III clinical trials to multiple sclerosis patients in routine clinical care - Kris Oliver Jalusic, David Ellenberger, Paulus Rommer, Alexander Stahmann, Uwe Zettl,](https://journals.sagepub.com/na101/home/literatum/publisher/sage/journals/content/msja/2021/msja_27_12/1352458520985118/20211007/images/medium/10.1177_1352458520985118-table1.gif)
Effect of applying inclusion and exclusion criteria of phase III clinical trials to multiple sclerosis patients in routine clinical care - Kris Oliver Jalusic, David Ellenberger, Paulus Rommer, Alexander Stahmann, Uwe Zettl,
Effect of applying inclusion and exclusion criteria of phase III clinical trials to multiple sclerosis patients in routine clini
![Neue Medikamente und altbekannte Tabus bei Multipler Sklerose - AMSEL aktuell - Multiple Sklerose News - AMSEL e.V. Neue Medikamente und altbekannte Tabus bei Multipler Sklerose - AMSEL aktuell - Multiple Sklerose News - AMSEL e.V.](https://www.amsel.de/fileadmin/_processed_/b/2/csm_buttmann_patientengespraech_quelle_ckbm_510_feeb2409d2.jpg)
Neue Medikamente und altbekannte Tabus bei Multipler Sklerose - AMSEL aktuell - Multiple Sklerose News - AMSEL e.V.
![Jochen ULZHEIMER | Ltd. Oberarzt | Caritas Krankenhaus Bad Mergentheim, Bad Mergentheim | Neurologie Jochen ULZHEIMER | Ltd. Oberarzt | Caritas Krankenhaus Bad Mergentheim, Bad Mergentheim | Neurologie](https://i1.rgstatic.net/ii/profile.image/281146454757416-1444041946917_Q512/Jochen-Ulzheimer.jpg)